An Analytical Model of Leakage Neutron Equivalent Dose for Passively-Scattered Proton Radiotherapy and Validation with Measurements

Exposure to stray neutrons increases the risk of second cancer development after proton therapy. Previously reported analytical models of this exposure were difficult to configure and had not been investigated below 100 MeV proton energy. The purposes of this study were to test an analytical model o...

Full description

Bibliographic Details
Main Authors: Christopher Schneider, Wayne Newhauser, Jad Farah
Format: Article
Language:English
Published: MDPI AG 2015-05-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/7/2/795
id doaj-d68b899254ed4c9d8ae7e479a3639ff0
record_format Article
spelling doaj-d68b899254ed4c9d8ae7e479a3639ff02020-11-24T23:37:22ZengMDPI AGCancers2072-66942015-05-017279581010.3390/cancers7020795cancers7020795An Analytical Model of Leakage Neutron Equivalent Dose for Passively-Scattered Proton Radiotherapy and Validation with MeasurementsChristopher Schneider0Wayne Newhauser1Jad Farah2Department of Physics and Astronomy, Louisiana State University and Agricultural and Mechanical College, 202 Nicholson Hall, Baton Rouge, LA 70803, USADepartment of Physics and Astronomy, Louisiana State University and Agricultural and Mechanical College, 202 Nicholson Hall, Baton Rouge, LA 70803, USAInstitut de Radioprotection et de Sûreté Nucléaire, Service de Dosimétrie Externe, BP-17, 92262 Fontenay-aux-Roses, FranceExposure to stray neutrons increases the risk of second cancer development after proton therapy. Previously reported analytical models of this exposure were difficult to configure and had not been investigated below 100 MeV proton energy. The purposes of this study were to test an analytical model of neutron equivalent dose per therapeutic absorbed dose  at 75 MeV and to improve the model by reducing the number of configuration parameters and making it continuous in proton energy from 100 to 250 MeV. To develop the analytical model, we used previously published H/D values in water from Monte Carlo simulations of a general-purpose beamline for proton energies from 100 to 250 MeV. We also configured and tested the model on in-air neutron equivalent doses measured for a 75 MeV ocular beamline. Predicted H/D values from the analytical model and Monte Carlo agreed well from 100 to 250 MeV (10% average difference). Predicted H/D values from the analytical model also agreed well with measurements at 75 MeV (15% average difference). The results indicate that analytical models can give fast, reliable calculations of neutron exposure after proton therapy. This ability is absent in treatment planning systems but vital to second cancer risk estimation.http://www.mdpi.com/2072-6694/7/2/795proton therapyneutron equivalent doseanalytical model
collection DOAJ
language English
format Article
sources DOAJ
author Christopher Schneider
Wayne Newhauser
Jad Farah
spellingShingle Christopher Schneider
Wayne Newhauser
Jad Farah
An Analytical Model of Leakage Neutron Equivalent Dose for Passively-Scattered Proton Radiotherapy and Validation with Measurements
Cancers
proton therapy
neutron equivalent dose
analytical model
author_facet Christopher Schneider
Wayne Newhauser
Jad Farah
author_sort Christopher Schneider
title An Analytical Model of Leakage Neutron Equivalent Dose for Passively-Scattered Proton Radiotherapy and Validation with Measurements
title_short An Analytical Model of Leakage Neutron Equivalent Dose for Passively-Scattered Proton Radiotherapy and Validation with Measurements
title_full An Analytical Model of Leakage Neutron Equivalent Dose for Passively-Scattered Proton Radiotherapy and Validation with Measurements
title_fullStr An Analytical Model of Leakage Neutron Equivalent Dose for Passively-Scattered Proton Radiotherapy and Validation with Measurements
title_full_unstemmed An Analytical Model of Leakage Neutron Equivalent Dose for Passively-Scattered Proton Radiotherapy and Validation with Measurements
title_sort analytical model of leakage neutron equivalent dose for passively-scattered proton radiotherapy and validation with measurements
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2015-05-01
description Exposure to stray neutrons increases the risk of second cancer development after proton therapy. Previously reported analytical models of this exposure were difficult to configure and had not been investigated below 100 MeV proton energy. The purposes of this study were to test an analytical model of neutron equivalent dose per therapeutic absorbed dose  at 75 MeV and to improve the model by reducing the number of configuration parameters and making it continuous in proton energy from 100 to 250 MeV. To develop the analytical model, we used previously published H/D values in water from Monte Carlo simulations of a general-purpose beamline for proton energies from 100 to 250 MeV. We also configured and tested the model on in-air neutron equivalent doses measured for a 75 MeV ocular beamline. Predicted H/D values from the analytical model and Monte Carlo agreed well from 100 to 250 MeV (10% average difference). Predicted H/D values from the analytical model also agreed well with measurements at 75 MeV (15% average difference). The results indicate that analytical models can give fast, reliable calculations of neutron exposure after proton therapy. This ability is absent in treatment planning systems but vital to second cancer risk estimation.
topic proton therapy
neutron equivalent dose
analytical model
url http://www.mdpi.com/2072-6694/7/2/795
work_keys_str_mv AT christopherschneider ananalyticalmodelofleakageneutronequivalentdoseforpassivelyscatteredprotonradiotherapyandvalidationwithmeasurements
AT waynenewhauser ananalyticalmodelofleakageneutronequivalentdoseforpassivelyscatteredprotonradiotherapyandvalidationwithmeasurements
AT jadfarah ananalyticalmodelofleakageneutronequivalentdoseforpassivelyscatteredprotonradiotherapyandvalidationwithmeasurements
AT christopherschneider analyticalmodelofleakageneutronequivalentdoseforpassivelyscatteredprotonradiotherapyandvalidationwithmeasurements
AT waynenewhauser analyticalmodelofleakageneutronequivalentdoseforpassivelyscatteredprotonradiotherapyandvalidationwithmeasurements
AT jadfarah analyticalmodelofleakageneutronequivalentdoseforpassivelyscatteredprotonradiotherapyandvalidationwithmeasurements
_version_ 1725520224080363520